discuss with I'll of cash for our discussion . Josh. call. activity the quarter our and you and our first Thanks, joining morning, and flow 'XX results, operating first for quarter outlook. the capital Good a allocation thank conclude
XX, $XXX.X as contribution growth XXXX, in the X For from And improving was the X quarter. X.X%, in as February March non-acquired Non-acquired growth a contribution quarter's year-over-year growth point expected, versus converging also of the months growth Solara. XXXX our closed the XXXX. including including net from quarter full quarter that revenue and Organic of of organic are lapped for AeroCare the quarter. ending acquisition AdaptHealth and first X.X% we quarter reported representing larger year-ago for about growth acquisitions, fourth XX.X%, million, AeroCare was the
As reflected and and the from Philips' HME despite our our noted, quarter and particularly volumes revenue performance Results were from with and the the impact also internal resupply ongoing in PAP Steve of chain strong better-than-expected products, a consistent EBITDA patient we ability diabetes to the shortage. which in first sleep PAP with deliver benefited pleased adjusted for expectations, device recall categories, supply our despite solid challenges. performance
supply higher As chain cost impacted and results. challenges have our expected,
our mitigate technology. we scaling Steve as leveraging Josh and to by taking are steps have these However, and described, pressures
technology these patient delivery such, saw technologies. as previous expected for highlighted and including as well our calls, the Oracle OTL, As in increase strategic on platform, we quarter. the investments other expense We've
confident achieving Although we out very are utilize tools G&A we we of inefficiencies EBITDA in investments anticipate rebound to remain increased margin our as quarters, that at implies the other full-year to in operating accelerate XX.X% current these we leverage guidance margins out pool and will of levels our that and drive operating cost future expenses. these midpoint. labor We adjusted and expense, from confident
continued equipment CapEx, as we evolution it in little a of in CapEx. longer increases as effort patient total our adjusted but This business reflects to noted, with very reporting simplify, the diabetes is percent also As revenue an mix. no EBITDA-less are previously
are and We light Like the factors eliminating continue flow guide in quarter cash year million, of cash flows total [DSOs] impact payments. million cycle interest cash the of CapEx the $XX up with a of timing financing. million. to days to $XX.X the were and revenue change ago. paid $XX.X $XX.X Total providers, of and equipment cycle, from lease for first patient XX on variety will from and firm from focus XXXX, other quarter at flow ordering fourth the interest was healthcare held most historically cash million. a no operations through payroll patterns, generating expenditures was Overall, capital free
represented of CapEx inflation nonrecurring revenues, consistent to As activity in recoupment negative during Act Free of of higher This XX% X% includes was will guidance was our was Accounts use of than $XX end freight the quarter. spend flow relates the of revenue. to CARES $X.X due by the and it million expected, continue and payable our XX.X% surcharges to cash $XX done which This will be outflows historical the for with related to million. QX, quarter, implementation. a but ERP million. the cash
throughout flow spite track these cash improve trailing we quarter and the of improve year, as our cash will on work $XXX starting under revenue an we to revenue had convert in We as months we to next Net was the and use discounts, leverage, bank the X.Xx. cash. our XX should was X.Xx of so this In will as which and realize X% At leverage X% million balance pay off, of for to on defined beyond. that on revolver. remain X% QX, covenants, items of pay free this to expect should ROI XXXX, leverage we prompt of X% end, year X
XXXX Turning outlook. the to
guidance the that our emergency public of are range, quarter small another the We by acquisitions first in updating the the we reflecting days. primarily health XX completed extension and
relief additional X in quarter. is Additionally, sequestration of included the point
million we EBITDA would until billion, allocations now billion market is billion. guidance year. prior we the it to up to to million adjusted is the on of to $X.XXX with is entire range $XXX not from back the of that from that range previous ResMed in the previous Respironics that $X.XXX equipment February, $X.XXX $XXX our billion revenue year now to $X.XXX Recall up the range our already half million, will $XXX million. before provided And $XXX Specifically, assumes back and the the return of take range
include As for over is pass open thoughts from customary, closed. before call does now that I'll to for it contribution not Q&A. we guidance Steve our acquisitions up some we yet not final have the